- Home
- GEF vs VKTX Comparison
GEF vs VKTX Comparison
Compare GEF & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEF
- VKTX
- Stock Information
- Founded
- GEF 1877
- VKTX 2012
- Country
- GEF United States
- VKTX United States
- Employees
- GEF N/A
- VKTX N/A
- Industry
- GEF
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- GEF
- VKTX Health Care
- Exchange
- GEF Nasdaq
- VKTX Nasdaq
- Market Cap
- GEF 3.2B
- VKTX 2.8B
- IPO Year
- GEF N/A
- VKTX 2015
- Fundamental
- Price
- GEF $54.79
- VKTX $26.12
- Analyst Decision
- GEF Buy
- VKTX Buy
- Analyst Count
- GEF 7
- VKTX 12
- Target Price
- GEF $74.17
- VKTX $84.00
- AVG Volume (30 Days)
- GEF 109.3K
- VKTX 2.8M
- Earning Date
- GEF 06-04-2025
- VKTX 07-23-2025
- Dividend Yield
- GEF 3.95%
- VKTX N/A
- EPS Growth
- GEF N/A
- VKTX N/A
- EPS
- GEF 4.43
- VKTX N/A
- Revenue
- GEF $5,508,100,000.00
- VKTX N/A
- Revenue This Year
- GEF N/A
- VKTX N/A
- Revenue Next Year
- GEF $12.04
- VKTX N/A
- P/E Ratio
- GEF $12.32
- VKTX N/A
- Revenue Growth
- GEF 6.88
- VKTX N/A
- 52 Week Low
- GEF $48.23
- VKTX $18.92
- 52 Week High
- GEF $73.16
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- GEF 48.30
- VKTX 45.41
- Support Level
- GEF $54.91
- VKTX $26.66
- Resistance Level
- GEF $56.12
- VKTX $28.33
- Average True Range (ATR)
- GEF 0.92
- VKTX 1.37
- MACD
- GEF -0.14
- VKTX -0.20
- Stochastic Oscillator
- GEF 24.12
- VKTX 9.58
About GEF Greif Inc.
Greif Inc is a producer of industrial packaging products and services with manufacturing facilities located in many countries. It offers a comprehensive line of rigid industrial packaging products, such as steel, fiber, and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, transit protection products, water bottles and remanufactured and reconditioned industrial containers, and services, such as container life cycle management, blending, filling, logistics, warehousing, and other packaging services. The company operates in three reportable business segments including Global Industrial Packaging, Paper Packaging and Services, and Land Management. It operates in USA, Europe, Middle East, Africa and Asia and Other Americas.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.